Biotechnology: Biological Products (No Diagnostic Substances)

Business UpdateJul 27, 2026, 07:01 AM

OKYO Pharma to Participate in BTIG Biotech Conference

AI Summary

OKYO Pharma Limited announced its participation in the BTIG Biotechnology Conference 2026, scheduled virtually for July 28-29, 2026. The company will be represented by CEO Robert J. Dempsey, CFO Keeren Shah, and CMO Flavio Mantelli MD, PhD. Investors can schedule one-on-one meetings with management during the conference.

Key Highlights

OKYO Pharma to participate in the BTIG Biotechnology Conference 2026.
The virtual conference will take place on July 28-29, 2026.
CEO Robert J. Dempsey, CFO Keeren Shah, and CMO Flavio Mantelli MD, PhD will represent the company.
One-on-one meetings with management can be scheduled through BTIG representatives.

View SEC Filing

OKYO

Biotechnology: Biological Products (No Diagnostic Substances)

OKYO Pharma Ltd

Price Impact